j.lokken
TL2 · Wrocław
Contributes reviews on supplier material. Based in Wrocław.
Joined 3 February 2025 · last posted 2d
80 posts, newest first. Showing up to 150.
-
[2026 update] Documenting an adverse event properly Replied, post #22 · Safety › Adverse events · 26 Jul 2026 · 13 likes I have three months of notes on Documenting an adverse event and the honest summary is that the trend is real and the week-to-week numbers are noise. I nearly drew the…
-
eGFR fluctuation and the creatinine denominator problem — the long version Replied, post #26 · Clinical › Bloodwork · 22 Jul 2026 · 0 likes Glycaemic markers integrate over different periods. A point glucose and a longer-term marker disagreeing is not a contradiction; it is two different questions. Worth…
-
A calculator that gives a right answer to the wrong question Replied, post #35 · Data & Tools › Calculators · 18 Jul 2026 · 0 likes Unit-conversion tools are only as good as the assumption they make about the syringe. Ask what barrel and what graduation interval it assumed before trusting the units…
-
Forced degradation studies: designing one that is informative Replied, post #97 · Analytics › Method validation · 13 Jul 2026 · 30 likes Post #93 describes the usual case. This is about the unusual one. Forced degradation studies is well covered in the tag pages, and the older discussions are better than…
-
Coming back to: Where the four-week escalation interval comes from, and what it is not Replied, post #19 · Practice › Dosing & titration · 9 Jul 2026 · 0 likes That is consistent with mine, for whatever one more account is worth.
-
Follow-up: Sleep quality changes during weight loss Replied, post #65 · Wellbeing › Sleep · 9 Jul 2026 · 19 likes Sensible. I would want the same detail before I acted on it either.
-
Electrolyte supplements: which ones do anything Replied, post #46 · Nutrition & Training › Hydration & electrolytes · 3 Jul 2026 · 0 likes Post #44 describes the usual case. This is about the unusual one. The interaction between electrolyte handling and other medicines is a pharmacist question and is…
-
Revisiting: What pooling buys you and what it destroys Replied, post #76 · Evidence › Meta-analyses · 2 Jul 2026 · 11 likes The arithmetic in post #75 is right; the assumption feeding it is the part to check. Study quality and weighting: some meta-analyses weight all studies equally; others…
-
Semaglutide and gastric emptying — the mechanism behind most of the side-effect profile Replied, post #85 · Compounds › Semaglutide · 30 Jun 2026 · 8 likes Albumin binding is not a unique structural feature and nothing in the class lacks it, but the reversibility matters. Semaglutide binds albumin covalently through a…
-
Why this subcategory is stricter about sourcing than most Replied, post #41 · Compounds › Secretagogues & GH axis · 10 Jun 2026 · 0 likes Reconstitution volumes in this family are often small enough that dead volume in the syringe is a meaningful fraction of the dose. A fixed-needle insulin syringe is…
-
Revisiting: Mean kinetic temperature explained without the mathematics Replied, post #36 · Practice › Storage & stability · 31 May 2026 · 18 likes Clarity is a weak test. A solution can lose a significant fraction of its active content to degradation or adsorption while remaining perfectly clear. That is one…
-
[2026 update] Waist circumference technique and its repeatability Replied, post #13 · Outcomes › Progress reports · 30 May 2026 · 0 likes A single scale used throughout beats a more accurate scale introduced halfway through. Consistency beats accuracy for a trend.
-
GLP-1 receptor distribution: central and peripheral Replied, post #59 · Pharmacology › Receptor biology · 29 May 2026 · 0 likes I read post #57 twice before replying, because I had assumed the opposite. Amylin receptor signalling: amylin promotes satiety and slows gastric emptying through a…
-
An appeal that succeeded, with the letter structure — the long version Replied, post #15 · Access › Insurance & coverage · 25 May 2026 · 0 likes A clinician's supporting letter that addresses the criteria explicitly is worth considerably more than one that describes the patient generally.
-
Why the titration planner refuses to produce a schedule below a floor Replied, post #78 · Data & Tools › Calculators · 25 May 2026 · 0 likes An update on my earlier titration planner refuses post: the pattern held for another six weeks and then stopped, which I did not predict and cannot explain.
-
A widely repeated interaction claim that turns out to be unsupported — what changed since Replied, post #48 · Practice › Interactions · 21 May 2026 · 4 likes Building on post #47 rather than restating it. Nothing here is medical advice and an interaction question is one where the cost of a wrong forum answer is genuinely…
-
Why we ask for units every single time, with three examples of what goes wrong — what… Replied, post #12 · Start Here › How to Ask · 18 May 2026 · 19 likes A photograph of a vial is rarely useful and a photograph of a document usually is. Redact the identifiers before you post either. Someone will know this better than I…
-
Stability of BPC-157 in solution: what has been measured — one year on Replied, post #55 · Compounds › Repair & healing peptides · 17 May 2026 · 6 likes Stability of BPC-157 is worth one more sentence than it usually gets, and the sentence is the one about how the number was arrived at.
-
Follow-up: Tirzepatide and nausea: is the profile genuinely different or just… Replied, post #49 · Compounds › Tirzepatide · 14 May 2026 · 0 likes Tirzepatide and nausea would be much easier to settle if anyone reported the denominator. Almost nobody reports the denominator.
-
Residual solvents and scavengers: what is looked for — what changed since Replied, post #38 · Analytics › Impurities & related substances · 11 May 2026 · 1 like I had written a reply contradicting post #36 and deleted it. Here is what survived. Residual solvents and scavengers was covered in the wiki last year and the page has…
-
Personal or family history of medullary thyroid carcinoma — what changed since Replied, post #27 · Safety › Contraindications · 3 May 2026 · 3 likes This follows post #26 rather than contradicting it. Medullary thyroid carcinoma (personal or family history) or multiple endocrine neoplasia type 2: absolute…
-
Official shortage notices and what they authorise Replied, post #31 · Access › Shortages · 3 May 2026 · 0 likes The version of official shortage notices that I was taught turned out to be a teaching simplification. Useful, and not true in the way I had assumed it was.
-
Injection discomfort: needle gauge, volume, temperature, technique Replied, post #53 · Practice › Administration · 18 Apr 2026 · 8 likes Adding the measurement that post #52 says would settle it. If you have to inject at a different time of day than usual, that is a much smaller perturbation than it…
-
Adolescents: a distinct evidence base — one year on Replied, post #86 · Clinical › Special populations · 14 Apr 2026 · 0 likes Genetic and ancestry-related differences in response are asked about regularly and the published evidence is thin enough that the honest answer is short.
-
Spike-and-recover accuracy for a peptide assay Replied, post #111 · Analytics › Method validation · 10 Apr 2026 · 1 like Where a pharmacopoeial monograph exists, a method that follows it inherits a great deal of assurance. Almost nothing discussed here has one.
-
Half-life, steady state, and accumulation worked through — a second dataset Replied, post #98 · Pharmacology › Pharmacokinetics · 5 Mar 2026 · 13 likes I had written a reply contradicting post #94 and deleted it. Here is what survived. Half-life: semaglutide ≈ 165–184 hours (about a week). Tirzepatide ≈ 5 days.…
-
Revisiting: Absolute versus relative contraindications Replied, post #36 · Safety › Contraindications · 3 Mar 2026 · 3 likes On post #32 — agreed on the reasoning, with one qualification. Where a contraindication is relative rather than absolute, the reasoning usually appears in the…
-
Second pass at: The topic list is dense — is that deliberate? Replied, post #87 · Meta › Site feedback · 2 Mar 2026 · 20 likes Good question, well framed, and I would like to see it answered properly.
-
Realistic expectations for strength while losing weight quickly Replied, post #67 · Nutrition & Training › Resistance training · 1 Mar 2026 · 2 likes Answering the realistic expectations for strength question as asked, then the question I think is meant. As asked: yes, with the qualification below. As meant: it…
-
Measurement error in a self-reported exposure Replied, post #112 · Evidence › Study critique · 27 Feb 2026 · 2 likes Coming back to post #110, because the follow-up matters more than the original answer. The strongest argument against my own position on measurement error, stated as…
-
Coming back to: Washout: how long is long enough, and for what purpose Replied, post #49 · Pharmacology › Pharmacokinetics · 21 Feb 2026 · 0 likes Fine by me. I had wanted a stronger conclusion and there is not one available.
-
Journal club: orforglipron phase 2 and the non-peptide question Replied, post #4 · Evidence › Journal club · 20 Feb 2026 · 29 likes Picking up the opening post: that is the part I would want checked first. Reading this orforglipron phase 2 thread as someone who came in with a fixed view: the third…
-
Revisiting: Review: an evidence digest and the citation check that delayed it Replied, post #52 · Documentation › Doc review · 22 Jan 2026 · 1 like Where a review raises something the author disagrees with, recording the disagreement in the review thread is better than resolving it privately. Take the reasoning and…
-
[2026 update] Evidence quality in the secretagogue literature: an honest assessment Replied, post #12 · Compounds › Secretagogues & GH axis · 18 Jan 2026 · 3 likes This follows post #9 rather than contradicting it. I disagree with the framing of Evidence quality above, and I think it is a substantive disagreement rather than a…
-
Storing lyophilised material long term: what governs the shelf life Replied, post #15 · Practice › Storage & stability · 4 Jan 2026 · 2 likes Door storage in a refrigerator is the warmest and most variable position in the appliance. A shelf at the back is a materially different environment.
-
How to read a phase 2 result without treating it as a phase 3 result — what changed since Replied, post #24 · Compounds › Retatrutide · 18 Dec 2025 · 8 likes TRIUMPH is phase 3 and it is ongoing. No phase 3 results exist. Nothing should be attributed to TRIUMPH because the trial has not finished. When it does, this page will…
-
The decimal-point error, and the habit that catches it Replied, post #15 · Practice › Reconstitution · 14 Dec 2025 · 17 likes Preservative effectiveness is tested against a defined microbial challenge under defined conditions. It is not a licence to treat an entered vial as sterile…
-
Documentation that appears only after payment Replied, post #86 · Sourcing › Red flags · 24 Nov 2025 · 0 likes Reading back through, this was answered upthread and I missed it. My fault.
-
Why semaglutide solutions can look faintly opalescent and when that matters Replied, post #37 · Compounds › Semaglutide · 23 Nov 2025 · 15 likes On identity confirmation: a mass close to 4113.6 Da on the intact molecule is consistent with semaglutide and is also consistent with several closely related species.…
-
Temperature loggers worth the money — the long version Replied, post #78 · Devices › Cold chain · 20 Nov 2025 · 0 likes Post #77 is right about the mechanism and I think understates the practical bit. Temperature logging: devices that record temperature over time let you confirm cold…
-
Pen dose counters: what a click does and does not guarantee Replied, post #53 · Devices › Pens & autoinjectors · 16 Nov 2025 · 29 likes Reusability: some pens are single-use (throw away after one injection). Others can be reused until empty. Confirm which type you have. Reusing a single-use pen is…
-
[2026 update] Long-time reader, first-time poster Replied, post #23 · Lounge › Introductions · 6 Nov 2025 · 19 likes Long-time reader is worth one more sentence than it usually gets, and the sentence is the one about how the number was arrived at.
-
Semaglutide half-life: where the 165 to 184 hour figure comes from Replied, post #25 · Compounds › Semaglutide · 12 Oct 2025 · 3 likes Everything in post #23 holds. The case it does not cover is the one I have. Semaglutide versus liraglutide in STEP 8: semaglutide produced greater weight reduction and…
-
Detection wavelength and why 214 nm and 280 nm disagree Replied, post #56 · Analytics › HPLC & UHPLC · 29 Sep 2025 · 3 likes An observation about detection wavelength that I cannot explain and am posting anyway, on the principle that unexplained observations are more useful public than private.
-
Cost per delivered dose, which is the number that matters Replied, post #9 · Access › Pricing · 21 Sep 2025 · 6 likes Cost per week at a maintenance dose is the figure most people actually want and least often calculate. That is one dataset and I would not build a rule on it.
-
Tracking that stops updating and then resumes — the long version Replied, post #16 · Sourcing › Logistics · 18 Sep 2025 · 0 likes Tracking accuracy at each hop is a reasonable proxy for how much attention the shipment is getting, and it costs nothing to note. If that is already documented…
-
[2026 update] What the GIP component of tirzepatide is thought to contribute, and how… Replied, post #122 · Compounds › Tirzepatide · 10 Sep 2025 · 21 likes The five maintenance doses in the tirzepatide programme give a genuine dose-response curve, which is unusual. Most trials in this space compare one or two doses against…
-
Are there stupid questions here? A staff answer, at length Replied, post #82 · Start Here › Welcome · 17 Aug 2025 · 12 likes There is no stupid-questions rule and no penalty for asking badly. The response to a poorly framed question is a request for clarification, not rudeness. That is a…
-
[2026 update] Clearance pathways and what renal impairment changes Replied, post #60 · Pharmacology › Pharmacokinetics · 23 Jun 2025 · 12 likes Two claims get bundled together under Clearance pathways and they need separating. The descriptive one — this is what was observed — is usually well supported. The…
-
Reading an MS report that only gives you a single number Replied, post #112 · Analytics › Mass spectrometry · 19 Jun 2025 · 0 likes Post #108 and I disagree about the size of the effect, not about the direction. Calibration matters: a high-resolution instrument out of calibration can report mass…
-
Comparators chosen for regulatory reasons rather than clinical ones — one year on Replied, post #50 · Evidence › Trials · 11 Jun 2025 · 30 likes Building on post #49 rather than restating it. Multiplicity and multiple comparisons: if a trial tests many hypotheses, the chance of a false positive on at least one…
-
Pre-registering a personal experiment, seriously Replied, post #5 · Research Methods › N-of-1 designs · 25 May 2025 · 33 likes Agreed, and I will stop repeating the version of this I had been repeating.
-
Which panel is worth repeating and which is worth ignoring Replied, post #21 · Clinical › Bloodwork · 18 May 2025 · 19 likes Noted, and I have changed what I was going to do on the strength of it.
-
Airline travel with a temperature-sensitive injectable — what changed since Replied, post #26 · Devices › Cold chain · 11 May 2025 · 10 likes Post #25 answers the question as asked. The question underneath it is different. A cold pack still solid on day seven is a genuinely good sign about the packing and…
-
How Janoshik, Medutest, PeptideMeter and VendorInvestigate differ Replied, post #30 · Sourcing › Independent verification · 30 Apr 2025 · 5 likes Cost and turnaround: different services have different pricing and turnaround times. Janoshik's turnaround is weeks by mail; VendorInvestigate documentation review is…
-
TB-500 and thymosin beta-4: the fragment versus the protein Replied, post #3 · Compounds › Repair & healing peptides · 26 Apr 2025 · 3 likes Dose-response is unstudied in humans for essentially everything in this family, which means the confident numbers in circulation came from somewhere other than a trial.…
-
Why the timeline is on the right and not the left Replied, post #11 · Meta › Site feedback · 24 Apr 2025 · 1 like Timeline is well covered in the tag pages, and the older discussions are better than the recent ones because they were argued out properly. Worth twenty minutes before…
-
Reading an MS report that only gives you a single number Replied, post #45 · Analytics › Mass spectrometry · 5 Apr 2025 · 4 likes Resolution and mass accuracy are different specifications. An instrument can resolve two species and still assign their masses imprecisely, and the reverse is also…
-
Review: a draft on reconstitution arithmetic, with objections Replied, post #62 · Documentation › Doc review · 17 Mar 2025 · 0 likes I came in to disagree and I am leaving without a disagreement.
-
Transit times by route, from a logged dataset — the long version Replied, post #70 · Sourcing › Logistics · 14 Mar 2025 · 7 likes Transit times came up in a thread eighteen months ago and was answered well. I cannot find it, which is itself the problem, so here is the reconstruction.
-
Scheduled maintenance and what will be unavailable Replied, post #71 · Meta › Announcements · 13 Mar 2025 · 0 likes The practical version of scheduled maintenance is three sentences long. The rigorous version is three pages and reaches the same conclusion with the conditions attached.
-
Research-use-only status: what it means legally and practically — a second dataset Replied, post #111 · Compounds › Other compounds · 10 Mar 2025 · 0 likes Thymosin alpha-1 has a regulatory history in several jurisdictions and a real clinical literature, which puts it in a different evidential category from most of its…
-
Pharmaceutical compounding rules, summarised from primary sources Replied, post #32 · Sourcing › Regulatory · 28 Feb 2025 · 3 likes Post #28 put the caveat in the right place and I want to underline it. Primary documents matter: regulatory positions are published in official documents. Reading the…
-
Research-use-only labelling: what it means and what it does not — the long version Replied, post #94 · Sourcing › Regulatory · 27 Feb 2025 · 31 likes Agreed on all of that, and I have nothing to add to it.
-
Revisiting: Bug report: the reconstitution calculator and a rounding edge case Replied, post #101 · Data & Tools › Calculators · 22 Feb 2025 · 12 likes Unit-conversion tools are only as good as the assumption they make about the syringe. Ask what barrel and what graduation interval it assumed before trusting the units…
-
Adjudicated events and why the definition matters — the long version Replied, post #15 · Evidence › Trials · 18 Feb 2025 · 0 likes Adding the measurement that post #13 says would settle it. An honest declaration on Adjudicated events: I have a prior here and it is strong enough that you should…
-
Second pass at: Regression to the mean in progress reports Replied, post #55 · Research Methods › Statistics · 14 Feb 2025 · 0 likes Agreed on all of that, and I have nothing to add to it.
-
Follow-up: What other technical communities get right that we do not Replied, post #16 · Lounge › Off topic · 12 Feb 2025 · 17 likes Industry and supply chain: post about manufacturing, pharmaceutical economics, or market dynamics if you have something substantive to contribute. A single observation,…
-
What we do not know about retatrutide, listed explicitly Replied, post #92 · Compounds › Retatrutide · 11 Feb 2025 · 20 likes On post #90 — agreed on the reasoning, with one qualification. Triple agonism: is the effect additive, synergistic, or neither? A phase 2 comparison of tirzepatide…
-
Coming back to: Reading a meta-analysis you disagree with, fairly Replied, post #31 · Evidence › Meta-analyses · 9 Feb 2025 · 23 likes Noted, and I have changed what I was going to do on the strength of it.
-
Revisiting: Bug report: the reconstitution calculator and a rounding edge case Replied, post #78 · Data & Tools › Calculators · 5 Feb 2025 · 5 likes I had written a reply contradicting post #77 and deleted it. Here is what survived. Do the arithmetic by hand the first few times, whatever tool you use afterwards. A…
-
Checking someone else's arithmetic: a worked example thread Replied, post #17 · Practice › Reconstitution · 26 Jan 2025 · 29 likes Preservative effectiveness is tested against a defined microbial challenge under defined conditions. It is not a licence to treat an entered vial as sterile…
-
Recovery when intake is low: what to cut first Replied, post #42 · Nutrition & Training › Resistance training · 12 Jan 2025 · 21 likes Worth stating the null on recovery before we explain it: the observation may be nothing. That possibility deserves a sentence and usually does not get one.
-
A page that has drifted out of date and needs a maintainer Replied, post #33 · Documentation › Wiki requests · 27 Nov 2024 · 1 like Worth separating two things that post #29 runs together. Say what would make the page wrong. A page whose failure conditions are stated is much easier to review honestly.
-
Identical chromatograms across two different lots Replied, post #53 · Sourcing › Red flags · 23 Nov 2024 · 8 likes Speaking only to identical chromatograms as I have actually seen it, rather than as it is usually described: the effect is real, it is smaller than the thread suggests,…
-
Time to steady state after a dose increase Replied, post #27 · Pharmacology › Pharmacokinetics · 3 Nov 2024 · 0 likes Steady state is approached in roughly four to five half-lives. For a compound with a week-long half-life that is four to five weeks, which is where the escalation…
-
PIONEER 6 cardiovascular safety, read as a safety trial rather than an efficacy one —… Replied, post #21 · Compounds › Oral incretins · 16 Sep 2024 · 3 likes PIONEER programme is phase 3 for oral semaglutide. The trials cover multiple indications and durations. Reading them requires attention to which trial is which because…
-
Coming back to: Pricing far outside the range, in either direction Replied, post #11 · Sourcing › Red flags · 25 Jul 2024 · 0 likes Where I would push back on the Pricing far outside the range consensus is the confidence, not the direction. The direction looks right. The confidence is borrowed.
-
The mass-error checker and its intended scope Replied, post #126 · Data & Tools › Calculators · 15 Jul 2024 · 14 likes A saved calculation is worth more than a remembered one. Write down the inputs alongside the result, because the result alone is unverifiable a month later. Nothing…
-
Tracking a preprint to publication: a worked example — the long version Replied, post #16 · Evidence › Preprints · 14 Jul 2024 · 9 likes Narrowing post #13, because the general version has more than one answer. A preprint that has been up for two years without appearing in a journal is telling you…